VIVXF - Avivagen Inc. (VIVXF)(VIV:CA) - 6.3 Tonne Order Received

New Order. Avivagen signed a significant new purchase agreement to supply its largest customer in Asia with a 6.3 tonne order of OxC-beta Livestock. The shipment represents a 43% increase in size over the customer’s previous order and continues a trend of increased reorder size among this and other OxC-beta customers worldwide.UNAHCO. Although the Company did not release the name of the customer, we believe it is UNAHCO, out of the Philippines. Since its initial November 2016 order of 150 kilograms of OxC-beta, the growth in UNAHCO's orders is stunning. Just starting in November 2019, orders grew from 2.1 tonnes, to 3.0 tonnes in April 2020, to 4.0 tonnes in October 2020, to 4.4 tonnes in April 2021, to the 6.3 tonne order announced yesterday. This ongoing increase in order size for OxC-beta amid a global pandemic is a sign of the positive impact that integration of Avivagen products can have on customer’s bottom line, in our view.Another Positive Development. We view the order announcement as another positive sign for Avivagen, along with the recent AB Vista distribution agreement focused on the U.S., Brazil, and Thailand markets, the retention of Mr. Lesley Nernberg as a technical sales and marketing consultant, focused on accelerating the adoption of OxC-beta Livestock in Asia, and the selection of Meyenberg International Group to lead expansion efforts in key regions in Central and South America.Maintaining Outperform. We are maintaining our Outperform rating and US$1.00 12-month price target. Avivagen is an early-stage revenue company focused on developing and commercializing products for livestock, companion animals, and humans. We believe the Company is at an inflection point with significant sales increases just around the corner and presents a favorable risk/reward proposition. Read More >>